We are live on ! Find out more
WG

Winton Group Portfolio holdings

AUM $3.09B
1-Year Est. Return 40.4%
This Fund
S&P 500
This Quarter Est. Return
+21.95%
1 Year Est. Return
+40.4%
3 Year Est. Return
+127.75%
5 Year Est. Return
+204.31%
10 Year Est. Return
+963.72%
AUM
$1.39B
AUM Growth
-$1.69B
Cap. Flow
-$2.06B
Cap. Flow %
-148.56%
Top 10 Hldgs %
17%
Holding
1,625
New
174
Increased
68
Reduced
1,053
Closed
325

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$12.4M
2
ROL icon
Rollins
ROL
+$7.74M
3
MKC icon
McCormick & Company Non-Voting
MKC
+$6.09M
4
XLI icon
State Street Industrial Select Sector SPDR ETF
XLI
+$4.85M
5
SF
Stifel
SF
+$3.99M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$18.2M
2
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$13.5M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$13.1M
4
KMB icon
Kimberly-Clark
KMB
+$12.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10.7M

Sector Composition

Rank Sector Weight
1 Financials 16.52%
2 Consumer Discretionary 13.29%
3 Healthcare 12.02%
4 Industrials 11.54%
5 Technology 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TREC
1276
DELISTED
Trecora Resources
TREC
$71K 0.01%
10,201
-23,231
-69% -$156K
ORMP icon
1277
Oramed Pharmaceuticals
ORMP
$175M
$69K 0.01%
16,375
-11,963
-42% -$38.9K
FNHC
1278
DELISTED
FedNat Holding Company Common Stock
FNHC
$66K ﹤0.01%
11,205
-14,751
-57% -$84.2K
ASRT
1279
DELISTED
Assertio
ASRT
$64K ﹤0.01%
2,973
-2,254
-43% -$70.1K
NBRV
1280
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$64K ﹤0.01%
1,054
-1,481
-58% -$160K
LCTX icon
1281
Lineage Cell Therapeutics
LCTX
$286M
$61K ﹤0.01%
34,771
-32,761
-49% -$45.8K
CASI
1282
DELISTED
CASI Pharmaceuticals
CASI
$58K ﹤0.01%
1,980
-5,703
-74% -$124K
CRBP icon
1283
Corbus Pharmaceuticals
CRBP
$177M
$58K ﹤0.01%
+1,558
New +$58.2K
STSA
1284
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$55K ﹤0.01%
+11,911
New +$51.3K
BCLI
1285
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$54K ﹤0.01%
798
-5,699
-88% -$776K
METC icon
1286
Ramaco Resources Class A
METC
$645M
$53K ﹤0.01%
19,167
+2,497
+15% +$7.58K
VSTM icon
1287
Verastem
VSTM
$615M
$53K ﹤0.01%
+2,056
New +$41.3K
GERN icon
1288
Geron
GERN
$949M
$47K ﹤0.01%
29,513
-41,083
-58% -$74.8K
AXAS
1289
DELISTED
Abraxas Petroleum Corp
AXAS
$47K ﹤0.01%
20,431
-3,521
-15% -$8.23K
NINE
1290
DELISTED
Nine Energy Service
NINE
$46K ﹤0.01%
17,029
-18,166
-52% -$33.4K
PULM icon
1291
Pulmatrix
PULM
$5.73M
$44K ﹤0.01%
1,856
-69
-4% -$1.64K
EMAN
1292
DELISTED
eMagin Corporation
EMAN
$41K ﹤0.01%
+24,933
New +$32K
PHX
1293
DELISTED
PHX Minerals
PHX
$39K ﹤0.01%
16,818
-21,070
-56% -$38.2K
ZSAN
1294
DELISTED
Zosano Pharma Corporation
ZSAN
$35K ﹤0.01%
1,911
-1,523
-44% -$29.8K
SENS icon
1295
Senseonics Holdings Inc
SENS
$394M
$21K ﹤0.01%
1,206
-503
-29% -$4.38K
IBIO icon
1296
iBio
IBIO
$69.5M
$18K ﹤0.01%
34
-28
-45% -$22.8K
GEN
1297
DELISTED
Genesis Healthcare, Inc.
GEN
$18K ﹤0.01%
36,159
+8,468
+31% +$4.28K
AAT
1298
American Assets Trust
AAT
$1.38B
– –
-46,901
Closed -$1.13M
ABG icon
1299
Asbury Automotive
ABG
$3.78B
– –
-3,645
Closed -$355K
ABR icon
1300
Arbor Realty Trust
ABR
$1,000M
– –
-45,160
Closed -$518K
50 51
52
53 54

Similar funds

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return

Winton Group's Q4 2020 Portfolio in Review

As of Q4 2020, Winton Group held 1,625 positions worth $1.39B, down 55% from $3.08B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Winton Group withdrew a net $2.06B in Q4 2020, closing 325 positions and reducing 1,053 holdings. Its most notable exit was Immunomedics Inc, an estimated $8.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Winton Group opened a new position in Stifel worth $4.52M.

  • Winton Group's largest Q4 2020 buy was Stifel: 134,360 shares worth $4.52M.
  • Winton Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2020, an estimated $12.4M increase.
  • Winton Group's biggest Q4 2020 reduction was Edwards Lifesciences, cutting an estimated $18.2M.
  • Winton Group fully exited Immunomedics Inc in Q4 2020, selling an estimated $8.1M.
  • Winton Group's ten largest holdings make up 17% of its $1.39B portfolio in Q4 2020.
  • Winton Group opened 174 new positions and closed 325 in Q4 2020.
  • Winton Group's portfolio value fell 55% quarter-over-quarter to $1.39B.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.